Keywords: glaxosmithkline, announces, board, committee, changes, tadataka, yamada

GlaxoSmithKline announces board and committee changes

Article | 22 December 2003

Print This

Tadataka Yamada, chairman, pharmaceuticals R&D at GlaxoSmithKline, hasbeen appointed an executive director of the group, and Sir Ian Prosser ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in